Ever Source Wealth Advisors, LLC Larimar Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 734 shares of LRMR stock, worth $3,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
734
Previous 198
270.71%
Holding current value
$3,126
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LRMR
# of Institutions
126Shares Held
65.9MCall Options Held
4.83MPut Options Held
83.7K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$90.4 Million1.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$25.8 Million0.38% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.93MShares$21 Million7.71% of portfolio
-
Opaleye Management Inc. Boston, MA4.11MShares$17.5 Million2.84% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.66MShares$15.6 Million0.01% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $184M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...